Page last updated: 2024-08-24

valsartan and Uterine Neoplasms

valsartan has been researched along with Uterine Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ernst, MT; Hallas, J; Johansen, NB; Kristensen, KB; Pottegård, A; Quartarolo, P1

Other Studies

1 other study(ies) available for valsartan and Uterine Neoplasms

ArticleYear
Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
    BMJ (Clinical research ed.), 2018, Sep-12, Volume: 362

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cohort Studies; Colorectal Neoplasms; Denmark; Dimethylnitrosamine; Drug Contamination; Female; Humans; Male; Middle Aged; Neoplasms; Risk Factors; Uterine Neoplasms; Valsartan

2018
chemdatabank.com